14.05
Schlusskurs vom Vortag:
$14.00
Offen:
$14
24-Stunden-Volumen:
77,045
Relative Volume:
0.82
Marktkapitalisierung:
$1.25B
Einnahmen:
$694.52M
Nettoeinkommen (Verlust:
$142.73M
KGV:
9.1277
EPS:
1.539
Netto-Cashflow:
$166.04M
1W Leistung:
-0.21%
1M Leistung:
+0.50%
6M Leistung:
-6.34%
1J Leistung:
-25.60%
Afya Ltd Stock (AFYA) Company Profile
Compare AFYA vs EDU, TAL, GHC, LAUR, CVSA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
AFYA
Afya Ltd
|
14.03 | 1.25B | 694.52M | 142.73M | 166.04M | 1.539 |
|
EDU
New Oriental Education Technology Group Inc Adr
|
46.63 | 7.39B | 5.39B | 456.61M | 911.26M | 2.6369 |
|
TAL
Tal Education Group Adr
|
9.77 | 5.95B | 3.02B | 532.43M | 603.71M | 0.9385 |
|
GHC
Graham Holdings Co
|
1,117.93 | 4.76B | 4.98B | 306.64M | 285.69M | 67.59 |
|
LAUR
Laureate Education Inc
|
33.28 | 4.64B | 1.74B | 281.99M | 263.59M | 1.8957 |
|
CVSA
Covista Inc
|
123.15 | 4.26B | 1.91B | 249.68M | 336.28M | 5.9265 |
Afya Ltd Stock (AFYA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2026-02-13 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2026-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-09-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-09-08 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-06 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2025-07-29 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-03-11 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-31 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-12-03 | Eingeleitet | Goldman | Sell |
| 2024-08-30 | Eingeleitet | UBS | Neutral |
| 2024-01-29 | Eingeleitet | Citigroup | Neutral |
| 2024-01-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-10-13 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-07-21 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-15 | Hochstufung | UBS | Neutral → Buy |
| 2021-02-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-28 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-08-19 | Eingeleitet | Credit Suisse | Neutral |
| 2020-05-20 | Herabstufung | UBS | Buy → Neutral |
| 2020-03-20 | Hochstufung | Itau BBA | Market Perform → Outperform |
| 2020-01-23 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-09-19 | Eingeleitet | UBS | Buy |
| 2019-08-13 | Eingeleitet | BofA/Merrill | Buy |
| 2019-08-13 | Eingeleitet | Goldman | Neutral |
| 2019-08-13 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-08-09 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Afya Ltd Aktie (AFYA) Neueste Nachrichten
Key Indicators - Intellectia AI
Income Statement - Intellectia AI
AFYA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
AFYA LTD-CLASS A (NASDAQ:AFYA): A Caviar Cruise Quality Screen Standout - ChartMill
AFYA or APEI: Which Is the Better Value Stock Right Now? - Yahoo Finance
Earnings call transcript: Afya’s Q1 2026 performance shows resilience - Investing.com UK
Afya (AFYA) CEO exercises 59K shares and reports tax-withholding of 16K shares - Stock Titan
[Form 4] Afya Ltd Insider Trading Activity - Stock Titan
Earnings call transcript: Afya’s Q1 2026 performance shows resilience By Investing.com - Investing.com Australia
Afya (AFYA) vice president exercises RSUs and increases direct share stake - Stock Titan
Afya (AFYA) CFO exercises RSUs and withholds 6,463 shares for tax obligations - Stock Titan
Afya (AFYA) vice president exercises RSUs as shares withheld for taxes - Stock Titan
Afya (AFYA) vice president exercises 7,000 RSUs and settles taxes with 1,925 shares - Stock Titan
Afya (AFYA) VP gains 10,200 shares from RSU vesting, holds 35,530 - Stock Titan
Afya (AFYA) controller exercises equity awards and uses shares for taxes - Stock Titan
Afya (AFYA) VP exercises RSUs, with 4,813 shares withheld for taxes - Stock Titan
TradingKey - TradingKey
Swedbank AB Grows Stock Holdings in Afya Limited $AFYA - MarketBeat
Afya Ltd (AFYA) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Competitive ... By GuruFocus - Investing.com Canada
Afya Q1 Earnings, Revenue Rise; Reaffirms 2026 Revenue Guidance - Moomoo
Afya (NASDAQ:AFYA) Stock Rating Lowered by Zacks Research - MarketBeat
Afya: Q1 Earnings Snapshot - 10TV
Earnings call transcript: Afya Q1 2026 shows growth amid margin pressure - Investing.com UK
Earnings call transcript: Afya Q1 2026 shows growth amid margin pressure By Investing.com - Investing.com India
Afya (NASDAQ:AFYA) Announces Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Afya Limited’s Revenue Reaches R$789.4 Million in Q1 2026, a 19.4% Increase Year-Over-Year - geneonline.com
Afya Ltd reports results for the quarter ended March 31Earnings Summary - TradingView
Afya Limited Announces First-Quarter 2026 Financial Results - Weekly Voice
Afya Limited 2026 Q1ResultsEarnings Call Presentation (NASDAQ:AFYA) 2026-05-07 - Seeking Alpha
Afya Q1 Earnings Call Highlights - MarketBeat
Afya Q1 2026 results: revenue hits R$1B, net income R$261M - grafa.com
Afya : Webcast PresentationAfya Limited 31 Mar 2026 - marketscreener.com
Afya (Nasdaq: AFYA) grows revenue and cash flow while paying dividends - Stock Titan
Afya (NASDAQ: AFYA) lifts Q1 2026 revenue and trims net debt - Stock Titan
Afya (AFYA) Projected to Post Earnings on Thursday - MarketBeat
Afya Q1 2026 Earnings Call Transcript - MarketBeat
Moody’s keeps Afya at AAA.br with a stable outlook - Stock Titan
Moody's Reaffirmed Afya's AAA.br Rating With a Stable Outlook - ChartMill
Afya (NASDAQ:AFYA) Rating Lowered to "Buy" at Wall Street Zen - MarketBeat
JPMorgan Chase & Co. Cuts Afya (NASDAQ:AFYA) Price Target to $21.50 - MarketBeat
J.P. Morgan Maintains Afya Ltd(AFYA.US) With Hold Rating, Cuts Target Price to $21.5 - Moomoo
Short Interest in Afya Limited (NASDAQ:AFYA) Declines By 18.0% - MarketBeat
MSN Money - MSN
Afya Limited (NASDAQ:AFYA) Given Average Rating of "Hold" by Analysts - MarketBeat
AFYA SEC FilingsAfya Limited 10-K, 10-Q, 8-K Forms - Stock Titan
Afya (AFYA) VP converts options into 19,000 Class A shares - Stock Titan
Afya (AFYA) VP converts options into 66,000 Class A shares - Stock Titan
BofA Securities Maintains Afya Ltd(AFYA.US) With Hold Rating, Maintains Target Price $17 - 富途牛牛
Is Afya (AFYA) Stock Undervalued Right Now? - Yahoo Finance
Afya Ltd (NASDAQ:AFYA) Passes the Quality Investing "Caviar Cruise" Screen - ChartMill
Insider Sell Alert: Santos Ferreira Sells Shares of Afya Ltd (AF - GuruFocus
Finanzdaten der Afya Ltd-Aktie (AFYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Afya Ltd-Aktie (AFYA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Junior Lelio de Souza | Vice President |
Apr 22 '26 |
Option Exercise |
11.83 |
66,000 |
780,780 |
66,000 |
| FERREIRA SANTOS WELDER | Controller |
Apr 17 '26 |
Sale |
15.90 |
3,325 |
52,868 |
35,000 |
| GRIFO DE SOUSA ANIBAL JOSE | VP Legal, Comp., & Gov Rel. |
Apr 13 '26 |
Sale |
15.41 |
14,000 |
215,770 |
31,000 |
| Junior Lelio de Souza | Vice President |
Apr 09 '26 |
Sale |
14.53 |
16,279 |
236,534 |
0 |
| Blanco Luis Andre Carpintero | Chief Financial Officer |
Apr 08 '26 |
Sale |
15.20 |
10,000 |
152,000 |
51,103 |
| Junior Lelio de Souza | Vice President |
Apr 07 '26 |
Sale |
14.95 |
26,753 |
399,957 |
16,279 |
| GRIFO DE SOUSA ANIBAL JOSE | VP Legal, Comp., & Gov Rel. |
Apr 07 '26 |
Sale |
15.20 |
5,000 |
76,000 |
45,000 |
| Gibbon Virgilio Deloy Capobian | Chief Executive Officer |
Apr 02 '26 |
Sale |
14.94 |
20,900 |
312,246 |
109,218 |
| Gibbon Virgilio Deloy Capobian | Chief Executive Officer |
Apr 06 '26 |
Sale |
14.91 |
770 |
11,481 |
108,448 |
| Gibbon Virgilio Deloy Capobian | Chief Executive Officer |
Apr 01 '26 |
Sale |
14.98 |
19,500 |
292,110 |
130,118 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):